申请人:Cypress Pharmaceuticals, Inc.
公开号:US20160256420A1
公开(公告)日:2016-09-08
The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.